S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
BREAKING: Tiny biotech successfully treats blindness (Ad)
Intensity and insults rise as lawmakers debate debt ceiling
UK travelers face hours-long waits for ferries to France
Unusual Passive Income Investment (Found on a Golf Course) (Ad)
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
Unusual Passive Income Investment (Found on a Golf Course) (Ad)
'War of the states': EV, chip makers lavished with subsidies
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
BREAKING: Tiny biotech successfully treats blindness (Ad)
Intensity and insults rise as lawmakers debate debt ceiling
UK travelers face hours-long waits for ferries to France
Unusual Passive Income Investment (Found on a Golf Course) (Ad)
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
Unusual Passive Income Investment (Found on a Golf Course) (Ad)
'War of the states': EV, chip makers lavished with subsidies
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
BREAKING: Tiny biotech successfully treats blindness (Ad)
Intensity and insults rise as lawmakers debate debt ceiling
UK travelers face hours-long waits for ferries to France
Unusual Passive Income Investment (Found on a Golf Course) (Ad)
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
Unusual Passive Income Investment (Found on a Golf Course) (Ad)
'War of the states': EV, chip makers lavished with subsidies
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
BREAKING: Tiny biotech successfully treats blindness (Ad)
Intensity and insults rise as lawmakers debate debt ceiling
UK travelers face hours-long waits for ferries to France
Unusual Passive Income Investment (Found on a Golf Course) (Ad)
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
Unusual Passive Income Investment (Found on a Golf Course) (Ad)
'War of the states': EV, chip makers lavished with subsidies
Lanterns and crescents: more retailers court Ramadan buyers
NASDAQ:LFCR

Lifecore Biomedical - LFCR Earnings Date, Estimates & Call Transcripts

$3.78
-0.02 (-0.53%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$3.72
▼
$3.97
50-Day Range
$1.67
▼
$7.02
52-Week Range
$1.52
▼
$11.95
Volume
486,362 shs
Average Volume
2.33 million shs
Market Capitalization
$114.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.50
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

LFCR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LFCR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Lifecore Biomedical Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20231($0.13)($0.13)($0.13)
Q4 20231$0.07$0.07$0.07
20232($0.06)($0.06)($0.06)
Q1 20241($0.18)($0.18)($0.18)
Q2 20241($0.02)($0.02)($0.02)
Q3 20241$0.07$0.07$0.07
Q4 20241$0.10$0.10$0.10
FY 20244($0.03)($0.03)($0.03)

LFCR Earnings Date and Information

Lifecore Biomedical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 4th, 2023 based off prior year's report dates.

Lifecore Biomedical Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/4/2023
(Estimated)		        
10/6/2022Q1 2023($0.12)($0.32)($0.20)($0.23)$42.55 million$43.36 million
8/10/2022Q4 2022($0.02)($0.01)+$0.01$1.22$46.78 million$47.63 million
4/5/2022Q3 2022($0.08)($0.08)$0.27$48.54 million$53.07 million
1/5/2022Q2 2022($0.08)($0.25)($0.17)$0.80$132.36 million$129.49 million
9/29/2021Q1 2022($0.11)($0.23)($0.12)($0.14)$128.25 million$128.79 million
7/28/2021Q4 2021($0.03)$0.07+$0.10$0.24$124.40 million$139.83 million
4/7/2021Q3 2021$0.02($0.09)($0.11)$0.01$139.75 million$137.78 million
1/6/2021Q2 2021$0.03$0.02($0.01)$0.49$134.24 million$130.90 million
10/6/2020Q1 2021($0.11)($0.11)$0.16$127.86 million$135.64 million
8/11/2020Q4 2020$0.03$0.05+$0.02$0.62$156.09 million$156.13 million
3/31/2020Q3 2020$0.01$0.04+$0.03$0.47$147.15 million$152.93 million
1/2/2020Q2 2020($0.06)($0.16)($0.10)($0.09)$142.53 million$142.59 million
10/1/2019Q1 2020($0.16)($0.16)($0.16)$131.14 million$138.71 million
7/30/2019Q4 2019$0.12+$0.12$0.25$152.78 million
4/3/2019Q3 2019$0.03$0.04+$0.01$0.04$156.47 million$155.69 million
10/2/2018Q1 2019$0.01+$0.01$0.01$123.94 million$124.67 million
7/31/2018Q4 2018$0.22$0.24+$0.02$0.26$138.61 million$141.08 million
4/3/2018Q3 2018$0.09$0.09($0.40)$146.09 million$149.32 million
1/3/2018Q2 2018$0.01$0.02+$0.01$0.02$135.82 million$136.46 million
9/26/2017Q1 2018$0.06$0.08+$0.02$0.08$123.00 million$123.36 million
7/25/2017Q4 2017$0.09$0.09$0.09$135.46 million$127.43 million
4/4/2017Q3 2017$0.12$0.13+$0.01$0.13$135.86 million$136.57 million
1/4/2017Q2 2017$0.06$0.05($0.01)$0.05$139.64 million$135.87 million
9/27/2016Q1 2017$0.10$0.12+$0.02$0.12$131.78 million$132.39 million
7/26/2016Q4 2016$0.15$0.17+$0.02$0.17$130.02 million$135.31 million
3/29/2016Q3 2016$0.03$0.01($0.02)$0.80$136.91 million$129.99 million
1/5/2016Q2 2016$0.06$0.07+$0.01$0.07$141.30 million$140.44 million
9/29/2015Q1 2016$0.13$0.11($0.02)$0.11$141.46 million$135.36 million
7/28/2015Q4 2015$0.19$0.15($0.04)$0.15$135.14 million$134.45 million
3/31/2015Q3 2015$0.17$0.17$0.20$135.73 million$138.53 million
1/6/2015Q2 2015$0.12+$0.12$0.12$130.71 million$132.67 million
10/7/2014Q1 2015$0.09$0.09$0.09$120.96 million$133.61 million
7/29/2014Q4 2014$0.18$0.17($0.01)$0.17$112.74 million$120.93 million
3/25/2014Q3 2014$0.23$0.24+$0.01$0.24$125.59 million$126.38 million
1/2/2014Q2 2014$0.13$0.13$0.13$123.96 million$120.03 million
9/24/2013Q1 2014$0.23$0.18($0.05)$0.18$109.36 million$109.48 million
7/31/2013Q4 2013$0.16$0.17+$0.01$0.17$104.10 million$107.11 million
3/26/2013Q3 2013$0.18$0.18$0.18$109.94 million$117.87 million












Lifecore Biomedical Earnings - Frequently Asked Questions

When is Lifecore Biomedical's earnings date?

Lifecore Biomedical has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 4th, 2023 based off last year's report dates. Learn more on LFCR's earnings history.

How much revenue does Lifecore Biomedical generate each year?

Lifecore Biomedical (NASDAQ:LFCR) has a recorded annual revenue of $182.86 million.

How much profit does Lifecore Biomedical generate each year?

Lifecore Biomedical (NASDAQ:LFCR) has a recorded net income of -$114.68 million. LFCR has generated -$2.50 earnings per share over the last four quarters.

What is Lifecore Biomedical's EPS forecast for next year?

Lifecore Biomedical's earnings are expected to grow from ($0.53) per share to ($0.08) per share in the next year.

More Earnings Resources from MarketBeat

Earnings Tools:
Earnings By Country:
Latest Articles:
Upcoming Earnings:
This page (NASDAQ:LFCR) was last updated on 4/1/2023 by MarketBeat.com Staff